HTA253 Analysis of HTA Assessments, Usage, and Reimbursement of Newly Introduced Outpatient Drugs in the Netherlands Between 2017 and 2021 – A Secondary Data Analysis

Abstract

Authors

M. van Wijk P. Pasman

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×